pharmacie et médicaments – Prise en charge des traitements innovants contre le myélome multiple

This written question concerns the coverage of innovative treatments for multiple myeloma, a type of blood cancer. It seeks clarification on how these advanced therapies are being made accessible to patients. The question is directed towards understanding the national policies and financial frameworks that ensure patients can benefit from cutting-edge medical advancements for this specific condition.